Atlas Trials

Dose Individualization of Pemetrexed - IMPROVE-II

Clinical trial NCT03655821 · TERMINATED

Trial details

NCT number
NCT03655821
Sponsor
Radboud University Medical Center
Status
TERMINATED
Phase
Phase 4
Study type
INTERVENTIONAL
Non Small Cell Lung CancerMesothelioma
Start date
2019-02-01
Primary completion
2021-05-11
Enrollment
81

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.